nach oben

Herzschrittmachertherapie + Elektrophysiologie

Erschienen in:

08.01.2018 | Schwerpunkt

Report on the Ion Channel Symposium

Organized by the German Cardiac Society Working Group on Cellular Electrophysiology (AG 18)

verfasst von: Niels Voigt, MD, Fleur Mason, Dierk Thomas

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

To support scientific exchange and activity in the field of cardiac cellular electrophysiology, the German Cardiac Society Working Group on Cellular Electrophysiology (AG 18) established a two-day symposium to be held every 2 years. The second Ion Channel Symposium entitled “Göttingen Channels 2017—Of Benches and Beds” took place in Göttingen from September 22nd to 23rd under the auspices of the German Cardiac Society. A group of national and international experts presented scientific advances in cardiac electrophysiology and rhythmology. The symposium’s primary focus was the significance of cellular electrophysiology findings for the optimization of diagnostic and therapeutic strategies against cardiac arrhythmias. To this end, speakers, chairpersons and attendees discussed the contribution of specific molecular alterations to the initiation and perpetuation of atrial and ventricular arrhythmias. Furthermore, the meeting highlighted how discoveries in electrophysiological research may lead to novel therapeutic targets. The interdisciplinary assessment of mechanisms and therapeutic strategies of cardiac arrhythmias represented a key feature of the meeting. A unique combination of topics and speakers representing both basic science and clinical electrophysiology ensured the scientific success of the “Göttingen Channels 2017” symposium. The next Ion Channel Symposium is planned to be hosted by the incoming co-chair of the German Cardiac Society Working Group on Cellular Electrophysiology in fall 2019.

Williams GS, Boyman L, Lederer WJ (2015) Mitochondrial calcium and the regulation of metabolism in the heart. J Mol Cell Cardiol 78:35–45. https://doi.org/10.1016/j.yjmcc.2014.10.019 CrossRefPubMed

McCormack JG, Halestrap AP, Denton RM (1990) Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev 70(2):391–425. https://doi.org/10.1152/physrev.1990.70.2.391 CrossRefPubMed

Kohlhaas M, Nickel AG, Maack C (2017) Mitochondrial energetics and calcium coupling in the heart. J Physiol 595(12):3753–3763. https://doi.org/10.1113/JP273609 CrossRefPubMed

Bers DM (2002) Cardiac excitation-contraction coupling. Nature 415(6868):198–205. https://doi.org/10.1038/415198a CrossRefPubMed

Hoppe UC (2010) Mitochondrial calcium channels. Febs Lett 584(10):1975–1981. https://doi.org/10.1016/j.febslet.2010.04.017 CrossRefPubMed

De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto R (2011) A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476(7360):336–340. https://doi.org/10.1038/nature10230 CrossRefPubMedPubMedCentral

Kwong JQ, Lu X, Correll RN, Schwanekamp JA, Vagnozzi RJ, Sargent MA, York AJ, Zhang J, Bers DM, Molkentin JD (2015) The mitochondrial calcium uniporter selectively matches metabolic output to acute contractile stress in the heart. Cell Rep 12(1):15–22. https://doi.org/10.1016/j.celrep.2015.06.002 CrossRefPubMedPubMedCentral

Boyman L, Williams GS, Khananshvili D, Sekler I, Lederer WJ (2013) NCLX: the mitochondrial sodium calcium exchanger. J Mol Cell Cardiol 59:205–213. https://doi.org/10.1016/j.yjmcc.2013.03.012 CrossRefPubMedPubMedCentral

Giorgio V, Guo L, Bassot C, Petronilli V, Bernardi P (2017) Calcium and regulation of the mitochondrial permeability transition. Cell Calcium. https://doi.org/10.1016/j.ceca.2017.05.004 PubMed

10.

Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6(5):513–519. https://doi.org/10.1038/74994 CrossRefPubMed

11.

Drago I, De Stefani D, Rizzuto R, Pozzan T (2012) Mitochondrial Ca²⁺ uptake contributes to buffering cytoplasmic Ca²⁺ peaks in cardiomyocytes. Proc Natl Acad Sci USA 109(32):12986–12991. https://doi.org/10.1073/pnas.1210718109 CrossRefPubMedPubMedCentral

12.

Boyman L, Chikando AC, Williams GS, Khairallah RJ, Kettlewell S, Ward CW, Smith GL, Kao JP, Lederer WJ (2014) Calcium movement in cardiac mitochondria. Biophys J 107(6):1289–1301. https://doi.org/10.1016/j.bpj.2014.07.045 CrossRefPubMedPubMedCentral

13.

Paillard M, Csordas G, Szanda G, Golenar T, Debattisti V, Bartok A, Wang N, Moffat C, Seifert EL, Spat A, Hajnoczky G (2017) Tissue-specific mitochondrial decoding of cytoplasmic Ca²⁺ signals is controlled by the stoichiometry of MICU1/2 and MCU. Cell Rep 18(10):2291–2300. https://doi.org/10.1016/j.celrep.2017.02.032 CrossRefPubMedPubMedCentral

14.

Lu J, Zang WJ, Yu XJ, Chen LN, Zhang CH, Jia B (2005) Effects of ischaemia-mimetic factors on isolated rat ventricular myocytes. Exp Physiol 90(4):497–505. https://doi.org/10.1113/expphysiol.2004.029421 CrossRefPubMed

15.

Ronchi C, Torre E, Rizzetto R, Bernardi J, Rocchetti M, Zaza A (2017) Late sodium current and intracellular ionic homeostasis in acute ischemia. Basic Res Cardiol 112(2):12. https://doi.org/10.1007/s00395-017-0602-9 CrossRefPubMed

16.

Kohlhaas M, Liu T, Knopp A, Zeller T, Ong MF, Bohm M, O’Rourke B, Maack C (2010) Elevated cytosolic Na⁺ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation 121(14):1606–1613. https://doi.org/10.1161/CIRCULATIONAHA.109.914911 CrossRefPubMedPubMedCentral

17.

Heinzel FR, Luo Y, Dodoni G, Boengler K, Petrat F, Di Lisa F, de Groot H, Schulz R, Heusch G (2006) Formation of reactive oxygen species at increased contraction frequency in rat cardiomyocytes. Cardiovasc Res 71(2):374–382. https://doi.org/10.1016/j.cardiores.2006.05.014 CrossRefPubMed

18.

Nickel AG, von Hardenberg A, Hohl M, Loffler JR, Kohlhaas M, Becker J, Reil JC, Kazakov A, Bonnekoh J, Stadelmaier M, Puhl SL, Wagner M, Bogeski I, Cortassa S, Kappl R, Pasieka B, Lafontaine M, Lancaster CR, Blacker TS, Hall AR, Duchen MR, Kastner L, Lipp P, Zeller T, Muller C, Knopp A, Laufs U, Bohm M, Hoth M, Maack C (2015) Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure. Cell Metab 22(3):472–484. https://doi.org/10.1016/j.cmet.2015.07.008 CrossRefPubMed

19.

Dudek J, Maack C (2017) Barth syndrome cardiomyopathy. Cardiovasc Res. https://doi.org/10.1093/cvr/cvx014 PubMed

20.

Aon MA, Cortassa S, Marban E, O’Rourke B (2003) Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J Biol Chem 278(45):44735–44744. https://doi.org/10.1074/jbc.M302673200 CrossRefPubMed

21.

Martin GM, Kandasamy B, DiMaio F, Yoshioka C, Shyng SL (2017) Anti-diabetic drug binding site in a mammalian K_ATP channel revealed by Cryo-EM. Elife 6. https://doi.org/10.7554/eLife.31054

22.

Arakel EC, Brandenburg S, Uchida K, Zhang H, Lin YW, Kohl T, Schrul B, Sulkin MS, Efimov IR, Nichols CG, Lehnart SE, Schwappach B (2014) Tuning the electrical properties of the heart by differential trafficking of K_ATP ion channel complexes. J Cell Sci 127(9):2106–2119. https://doi.org/10.1242/jcs.141440 CrossRefPubMedPubMedCentral

23.

Heijman J, Voigt N, Nattel S, Dobrev D (2014) Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res 114(9):1483–1499. https://doi.org/10.1161/circresaha.114.302226 CrossRefPubMed

24.

Wakili R, Voigt N, Kaab S, Dobrev D, Nattel S (2011) Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 121(8):2955–2968. https://doi.org/10.1172/jci46315 CrossRefPubMedPubMedCentral

25.

Li N, Chiang DY, Wang SF, Wang QL, Sun L, Voigt N, Respress JL, Ather S, Skapura DG, Jordan VK, Horrigan FT, Schmitz W, Muller FU, Valderrabano M, Nattel S, Dobrev D, Wehrens XHT (2014) Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model. Circulation 129(12):1276–1285. https://doi.org/10.1161/circulationaha.113.006611 CrossRefPubMedPubMedCentral

26.

Voigt N, Heijman J, Wang Q, Chiang DY, Li N, Karck M, Wehrens XH, Nattel S, Dobrev D (2014) Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 129(2):145–156. https://doi.org/10.1161/CIRCULATIONAHA.113.006641 CrossRefPubMed

27.

Voigt N, Li N, Wang Q, Wang W, Trafford AW, Abu-Taha I, Sun Q, Wieland T, Ravens U, Nattel S, Wehrens XH, Dobrev D (2012) Enhanced sarcoplasmic reticulum Ca²⁺ leak and increased Na⁺-Ca²⁺ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 125(17):2059–2070. https://doi.org/10.1161/CIRCULATIONAHA.111.067306 CrossRefPubMedPubMedCentral

28.

Voigt N, Trausch A, Knaut M, Matschke K, Varro A, Van Wagoner DR, Nattel S, Ravens U, Dobrev D (2010) Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol 3(5):472–480. https://doi.org/10.1161/CIRCEP.110.954636 CrossRefPubMed

29.

Schmidt C, Wiedmann F, Voigt N, Zhou XB, Heijman J, Lang S, Albert V, Kallenberger S, Ruhparwar A, Szabo G, Kallenbach K, Karck M, Borggrefe M, Biliczki P, Ehrlich JR, Baczko I, Lugenbiel P, Schweizer PA, Donner BC, Katus HA, Dobrev D, Thomas D (2015) Upregulation of K(2P)3.1 K⁺ current causes action potential shortening in patients with chronic atrial fibrillation. Circulation 132(2):82–92. https://doi.org/10.1161/CIRCULATIONAHA.114.012657 CrossRefPubMed

30.

Christ T, Boknik P, Wohrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D (2004) L‑type Ca²⁺ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 110(17):2651–2657. https://doi.org/10.1161/01.CIR.0000145659.80212.6A CrossRefPubMed

31.

Voigt N, Friedrich A, Bock M, Wettwer E, Christ T, Knaut M, Strasser RH, Ravens U, Dobrev D (2007) Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated I_K,ACh channels in patients with chronic atrial fibrillation. Cardiovasc Res 74(3):426–437. https://doi.org/10.1016/j.cardiores.2007.02.009 CrossRefPubMed

32.

Comtois P, Kneller J, Nattel S (2005) Of circles and spirals: bridging the gap between the leading circle and spiral wave concepts of cardiac reentry. Europace 7(Suppl 2):10–20. https://doi.org/10.1016/j.eupc.2005.05.011 CrossRefPubMed

33.

Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, Lau CP, Van Gelder IC, Hohnloser SH, Carlson M, Fain E, Nakamya J, Mairesse GH, Halytska M, Deng WQ, Israel CW, Healey JS, Investigators A (2014) Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 129(21):2094–2099. https://doi.org/10.1161/CIRCULATIONAHA.113.007825 CrossRefPubMed

34.

Spronk HM, De Jong AM, Verheule S, De Boer HC, Maass AH, Lau DH, Rienstra M, van Hunnik A, Kuiper M, Lumeij S, Zeemering S, Linz D, Kamphuisen PW, Ten Cate H, Crijns HJ, Van Gelder IC, van Zonneveld AJ, Schotten U (2017) Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation. Eur Heart J 38(1):38–50. https://doi.org/10.1093/eurheartj/ehw119 CrossRefPubMed

35.

Dawson K, Wakili R, Ordog B, Clauss S, Chen Y, Iwasaki Y, Voigt N, Qi XY, Sinner MF, Dobrev D, Kaab S, Nattel S (2013) MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 127(14):1466. https://doi.org/10.1161/CIRCULATIONAHA.112.001207 CrossRefPubMed

36.

Clauss S, Klier I, Schmidt V, Schuessler F, Siebermair J, Sinner M, Fichtner S, Estner H, Kääb S, Wakili R (2014) MicroRNAs as potential biomarkers of atrial fibrillation ablation therapy. Heart Rhythm 11(5 (Supplement)):AB36–6

37.

Clauss S, Sinner MF, Kaab S, Wakili R (2015) The role of microRNas in antiarrhythmic therapy for atrial fibrillation. Arrhythm Electrophysiol Rev 4(3):146–155. https://doi.org/10.15420/aer.2015.4.3.146 CrossRefPubMedPubMedCentral

38.

Molina CE, Voigt N (2017) Finding Ms or Mr right: which miRNA to target in AF? J Mol Cell Cardiol 102:22–25. https://doi.org/10.1016/j.yjmcc.2016.11.007 CrossRefPubMed

39.

Al Chekakie MO, Welles CC, Metoyer R, Ibrahim A, Shapira AR, Cytron J, Santucci P, Wilber DJ, Akar JG (2010) Pericardial fat is independently associated with human atrial fibrillation. J Am Coll Cardiol 56(10):784–788. https://doi.org/10.1016/j.jacc.2010.03.071 CrossRefPubMed

40.

Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G, Leong DP, Lau DH, Middeldorp ME, Roberts-Thomson KC, Wittert GA, Abhayaratna WP, Worthley SG, Sanders P (2011) Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol 57(17):1745–1751. https://doi.org/10.1016/j.jacc.2010.11.045 CrossRefPubMed

41.

Andrade J, Khairy P, Dobrev D, Nattel S (2014) The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res 114(9):1453–1468. https://doi.org/10.1161/CIRCRESAHA.114.303211 CrossRefPubMed

42.

Suffee N, Moore-Morris T, Farahmand P, Rucker-Martin C, Dilanian G, Fradet M, Sawaki D, Derumeaux G, LePrince P, Clement K, Dugail I, Puceat M, Hatem SN (2017) Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria. Proc Natl Acad Sci USA 114(5):E771–E780. https://doi.org/10.1073/pnas.1610968114 CrossRefPubMedPubMedCentral

43.

Venteclef N, Guglielmi V, Balse E, Gaborit B, Cotillard A, Atassi F, Amour J, Leprince P, Dutour A, Clement K, Hatem SN (2015) Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J 36(13):795–805a. https://doi.org/10.1093/eurheartj/eht099 CrossRefPubMed

44.

Ausma J, Coumans WA, Duimel H, Van der Vusse GJ, Allessie MA, Borgers M (2000) Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc Res 47(4):788–796. https://doi.org/10.1016/S0008-6363(00)00139-5 CrossRefPubMed

45.

Mihos CG, Krishna RK, Kherada N, Larrauri-Reyes M, Tolentino A, Santana O (2016) The use of ranolazine in non-anginal cardiovascular disorders: a review of current data and ongoing randomized clinical trials. Pharmacol Res 103:49–55. https://doi.org/10.1016/j.phrs.2015.10.018 CrossRefPubMed

46.

van Bragt KA, Nasrallah HM, Kuiper M, Luiken JJ, Schotten U, Verheule S (2014) Atrial supply-demand balance in healthy adult pigs: coronary blood flow, oxygen extraction, and lactate production during acute atrial fibrillation. Cardiovasc Res 101(1):9–19. https://doi.org/10.1093/cvr/cvt239 CrossRefPubMed

47.

Darby AE, Dimarco JP (2012) Management of atrial fibrillation in patients with structural heart disease. Circulation 125(7):945–957. https://doi.org/10.1161/CIRCULATIONAHA.111.019935 CrossRefPubMed

48.

Maisel WH, Stevenson LW (2003) Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 91(6A):2D–8DCrossRefPubMed

49.

Heijman J, Voigt N, Abu-Taha IH, Dobrev D (2013) Rhythm control of atrial fibrillation in heart failure. Heart Fail Clin 9(4):407–415. https://doi.org/10.1016/j.hfc.2013.06.001 CrossRefPubMed

50.

Wijesurendra RS, Liu A, Eichhorn C, Ariga R, Levelt E, Clarke WT, Rodgers CT, Karamitsos TD, Bashir Y, Ginks M, Rajappan K, Betts T, Ferreira VM, Neubauer S, Casadei B (2016) Lone atrial fibrillation is associated with impaired left ventricular energetics that persists despite successful catheter ablation. Circulation 134(15):1068–1081. https://doi.org/10.1161/CIRCULATIONAHA.116.022931 CrossRefPubMedPubMedCentral

51.

Yeh YH, Wakili R, Qi XY, Chartier D, Boknik P, Kaab S, Ravens U, Coutu P, Dobrev D, Nattel S (2008) Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol 1(2):93–102. https://doi.org/10.1161/CIRCEP.107.754788 CrossRefPubMed

52.

Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S (2003) Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 60(2):315–325CrossRefPubMed

53.

Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM (2003) Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 108(12):1461–1468. https://doi.org/10.1161/01.CIR.0000090688.49283.67 CrossRefPubMed

54.

Koumi S, Arentzen CE, Backer CL, Wasserstrom JA (1994) Alterations in muscarinic K⁺ channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts. Circulation 90(5):2213–2224. https://doi.org/10.1161/01.CIR.90.5.2213 CrossRefPubMed

55.

Fedorov VV, Glukhov AV, Ambrosi CM, Kostecki G, Chang R, Janks D, Schuessler RB, Moazami N, Nichols CG, Efimov IR (2011) Effects of K_ATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts. J Mol Cell Cardiol 51(2):215–225. https://doi.org/10.1016/j.yjmcc.2011.04.016 CrossRefPubMedPubMedCentral

56.

Schmidt C, Wiedmann F, Zhou XB, Heijman J, Voigt N, Ratte A, Lang S, Kallenberger SM, Campana C, Weymann A, De Simone R, Szabo G, Ruhparwar A, Kallenbach K, Karck M, Ehrlich JR, Baczko I, Borggrefe M, Ravens U, Dobrev D, Katus HA, Thomas D (2017) Inverse remodelling of K2P3.1 K⁺ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy. Eur Heart J 38(22):1764–1774. https://doi.org/10.1093/eurheartj/ehw559 PubMed

57.

Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V (1999) Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 44(1):121–131CrossRefPubMed

58.

Grandi E, Pandit SV, Voigt N, Workman AJ, Dobrev D, Jalife J, Bers DM (2011) Human atrial action potential and Ca²⁺ model: sinus rhythm and chronic atrial fibrillation. Circ Res 109(9):1055–1066. https://doi.org/10.1161/CIRCRESAHA.111.253955 CrossRefPubMedPubMedCentral

59.

Ravens U, Katircioglu-Ozturk D, Wettwer E, Christ T, Dobrev D, Voigt N, Poulet C, Loose S, Simon J, Stein A, Matschke K, Knaut M, Oto E, Oto A, Guvenir HA (2015) Application of the RIMARC algorithm to a large data set of action potentials and clinical parameters for risk prediction of atrial fibrillation. Med Biol Eng Comput 53(3):263–273. https://doi.org/10.1007/s11517-014-1232-0 CrossRefPubMed

60.

Schmidt C, Wiedmann F, Schweizer PA, Katus HA, Thomas D (2014) Inhibition of cardiac two-pore-domain K⁺ (K2P) channels—an emerging antiarrhythmic concept. Eur J Pharmacol 738:250–255. https://doi.org/10.1016/j.ejphar.2014.05.056 CrossRefPubMed

61.

Hohendanner F, DeSantiago J, Heinzel FR, Blatter LA (2016) Dyssynchronous calcium removal in heart failure-induced atrial remodeling. Am J Physiol Heart Circ Physiol 311(6):H1352–H1359. https://doi.org/10.1152/ajpheart.00375.2016 CrossRefPubMedPubMedCentral

62.

Hohendanner F, Walther S, Maxwell JT, Kettlewell S, Awad S, Smith GL, Lonchyna VA, Blatter LA (2015) Inositol-1,4,5-trisphosphate induced Ca²⁺ release and excitation-contraction coupling in atrial myocytes from normal and failing hearts. J Physiol 593(6):1459–1477. https://doi.org/10.1113/jphysiol.2014.283226 CrossRefPubMed

63.

Pinto AR, Ilinykh A, Ivey MJ, Kuwabara JT, D’Antoni ML, Debuque R, Chandran A, Wang L, Arora K, Rosenthal NA, Tallquist MD (2016) Revisiting cardiac cellular composition. Circ Res 118(3):400–409. https://doi.org/10.1161/CIRCRESAHA.115.307778 CrossRefPubMed

64.

Rohr S (2009) Myofibroblasts in diseased hearts: new players in cardiac arrhythmias? Heart Rhythm 6(6):848–856. https://doi.org/10.1016/j.hrthm.2009.02.038 CrossRefPubMed

65.

Gourdie RG, Dimmeler S, Kohl P (2016) Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease. Nat Rev Drug Discov 15(9):620–638. https://doi.org/10.1038/nrd.2016.89 CrossRefPubMedPubMedCentral

66.

Harada M, Luo X, Qi XY, Tadevosyan A, Maguy A, Ordog B, Ledoux J, Kato T, Naud P, Voigt N, Shi Y, Kamiya K, Murohara T, Kodama I, Tardif JC, Schotten U, Van Wagoner DR, Dobrev D, Nattel S (2012) Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation 126(17):2051–2064. https://doi.org/10.1161/CIRCULATIONAHA.112.121830 CrossRefPubMedPubMedCentral

67.

Kohl P, Gourdie RG (2014) Fibroblast-myocyte electrotonic coupling: does it occur in native cardiac tissue? J Mol Cell Cardiol 70:37–46. https://doi.org/10.1016/j.yjmcc.2013.12.024 CrossRefPubMedPubMedCentral

68.

Peyronnet R, Nerbonne JM, Kohl P (2016) Cardiac mechano-gated Ion channels and arrhythmias. Circ Res 118(2):311–329. https://doi.org/10.1161/CIRCRESAHA.115.305043 CrossRefPubMedPubMedCentral

69.

Gaudesius G, Miragoli M, Thomas SP, Rohr S (2003) Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res 93(5):421–428. https://doi.org/10.1161/01.RES.0000089258.40661.0C CrossRefPubMed

70.

Miragoli M, Gaudesius G, Rohr S (2006) Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ Res 98(6):801–810. https://doi.org/10.1161/01.RES.0000214537.44195.a3 CrossRefPubMed

71.

Miragoli M, Salvarani N, Rohr S (2007) Myofibroblasts induce ectopic activity in cardiac tissue. Circ Res 101(8):755–758. https://doi.org/10.1161/CIRCRESAHA.107.160549 PubMed

72.

Salvarani N, Maguy A, De Simone SA, Miragoli M, Jousset F, Rohr S (2017) TGF-beta1 (transforming growth factor-beta1) plays a pivotal role in cardiac myofibroblast arrhythmogenicity. Circ Arrhythm Electrophysiol 10(5):e4567. https://doi.org/10.1161/CIRCEP.116.004567 CrossRefPubMed

73.

Brado J, Dechant MJ, Menza M, Komancsek A, Lang CN, Bugger H, Foell D, Jung BA, Stiller B, Bode C, Odening KE (2017) Phase-contrast magnet resonance imaging reveals regional, transmural, and base-to-apex dispersion of mechanical dysfunction in patients with long QT syndrome. Heart Rhythm 14(9):1388–1397. https://doi.org/10.1016/j.hrthm.2017.04.045 CrossRefPubMed

74.

Lang CN, Menza M, Jochem S, Franke G, Feliz PS, Brunner M, Koren G, Zehender M, Bugger H, Jung BA, Foell D, Bode C, Odening KE (2016) Electro-mechanical dysfunction in long QT syndrome: role for arrhythmogenic risk prediction and modulation by sex and sex hormones. Prog Biophys Mol Biol 120(1):255–269. https://doi.org/10.1016/j.pbiomolbio.2015.12.010 CrossRefPubMed

75.

Loomba RS, Buelow MW, Aggarwal S, Arora RR, Kovach J, Ginde S (2017) Arrhythmias in adults with congenital heart disease: what are risk factors for specific arrhythmias? Pacing Clin Electrophysiol 40(4):353–361. https://doi.org/10.1111/pace.12983 CrossRefPubMed

76.

Knollmann BC (2013) Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model? Circ Res 112(6):969–976. https://doi.org/10.1161/CIRCRESAHA.112.300567 CrossRefPubMedPubMedCentral

77.

Myles RC, Bernus O, Burton FL, Cobbe SM, Smith GL (2010) Effect of activation sequence on transmural patterns of repolarization and action potential duration in rabbit ventricular myocardium. Am J Physiol Heart Circ Physiol 299(6):H1812–1822. https://doi.org/10.1152/ajpheart.00518.2010 CrossRefPubMedPubMedCentral

78.

Colatsky T, Fermini B, Gintant G, Pierson JB, Sager P, Sekino Y, Strauss DG, Stockbridge N (2016) The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative—update on progress. J Pharmacol Toxicol Methods 81:15–20. https://doi.org/10.1016/j.vascn.2016.06.002 CrossRefPubMed

79.

Nickel A, Loffler J, Maack C (2013) Myocardial energetics in heart failure. Basic Res Cardiol 108(4):358. https://doi.org/10.1007/s00395-013-0358-9 CrossRefPubMed

Titel: Report on the Ion Channel Symposium
Organized by the German Cardiac Society Working Group on Cellular Electrophysiology (AG 18)
verfasst von: Niels Voigt, MD
Fleur Mason
Dierk Thomas
Publikationsdatum: 08.01.2018
Verlag: Springer Medizin
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 1/2018
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI: https://doi.org/10.1007/s00399-017-0549-4

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Report on the Ion Channel Symposium

Organized by the German Cardiac Society Working Group on Cellular Electrophysiology (AG 18)

Abstract

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Effects of propofol sedation on pacing thresholds

Results from atrial fibrillation models and AF-patients

A new look at the heart—novel imaging techniques

Electromechanical heterogeneity in the heart

Advances in cardiac cellular electrophysiology – Relevance for clinical translation

Correction to: Atrial thrombogenesis in atrial fibrillation. Results from atrial fibrillation models and AF‑patients

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie